-
1دورية أكاديمية
المؤلفون: Musinguzi, A, Aschmann, HE, Kadota, JL, Nakimuli, J, Welishe, F, Kakeeto, J, Namale, C, Akello, L, Nakitende, A, Berger, C, Katamba, A, Tumuhamye, J, Kiwanuka, N, Dowdy, DW, Cattamanchi, A, Semitala, FC
المصدر: IJTLD open. 1(2)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Public Health, Health Sciences, Infectious Diseases, Sexually Transmitted Infections, Clinical Research, Prevention, HIV/AIDS, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Infection, Good Health and Well Being, acceptability, human immunodeficiency virus, tuberculosis preventive treatment, values
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/79s013sp
https://escholarship.org/content/qt79s013sp/qt79s013sp.pdf -
2دورية أكاديمية
المؤلفون: Sung, J, Musinguzi, A, Kadota, JL, Baik, Y, Nabunje, J, Welishe, F, Bishop, O, Berger, CA, Katahoire, A, Nakitende, A, Nakimuli, J, Akello, L, Kasidi, JR, Kunihira Tinka, L, Kamya, MR, Sohn, H, Kiwanuka, N, Katamba, A, Cattamanchi, A, Dowdy, DW, Semitala, FC
المصدر: The International Journal of Tuberculosis and Lung Disease. 27(6)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Health Sciences, Prevention, Clinical Research, Vaccine Related, Infectious Diseases, Infection, Good Health and Well Being, Male, Humans, Female, Isoniazid, Antitubercular Agents, Uganda, Tuberculosis, Latent Tuberculosis, Drug Therapy, Combination, Acquired Immunodeficiency Syndrome, Cardiorespiratory Medicine and Haematology, Microbiology, Cardiovascular medicine and haematology, Clinical sciences, Epidemiology
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/6vd7v38c
https://escholarship.org/content/qt6vd7v38c/qt6vd7v38c.pdf -
3دورية أكاديمية
المؤلفون: Kadota JL; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco CA USA., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Aschmann HE; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco CA USA., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakimuli J; Infectious Diseases Research Collaboration, Kampala, Uganda., Berger CA; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco CA USA., Kiwanuka N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda., Phillips PP; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco CA USA., Katamba A; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda., Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Cattamanchi A; Center for Tuberculosis, University of California San Francisco, San Francisco CA USA.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Orange CA USA., Semitala FC; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda.
المصدر: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Aug 09. Date of Electronic Publication: 2024 Aug 09.
نوع المنشور: Journal Article; Preprint
بيانات الدورية: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
-
4دورية أكاديمية
المؤلفون: Semitala FC; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala Uganda., Kadota JL; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Kunihira Tinka L; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakimuli J; Infectious Diseases Research Collaboration, Kampala, Uganda., Ritar Kasidi J; Infectious Diseases Research Collaboration, Kampala, Uganda., Bishop O; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakasendwa S; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda., Baik Y; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Patel D; The Better Lab and Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Sammann A; The Better Lab and Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Nahid P; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Belknap R; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America., Kamya MR; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda., Handley MA; Center for Vulnerable Populations, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America., Phillips PP; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Katahoire A; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Berger CA; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Kiwanuka N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda., Katamba A; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda., Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Cattamanchi A; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, California, United States of America.
المصدر: PLoS medicine [PLoS Med] 2024 Feb 20; Vol. 21 (2), pp. e1004356. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
نوع المنشور: Randomized Controlled Trial; Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
مواضيع طبية MeSH: Tuberculosis*/drug therapy , Tuberculosis*/prevention & control , Latent Tuberculosis*/drug therapy , HIV Infections*/complications , HIV Infections*/drug therapy, Rifampin/*analogs & derivatives, Humans ; Isoniazid/adverse effects ; Antitubercular Agents/adverse effects ; Uganda ; Drug Therapy, Combination
-
5
المؤلفون: Aschmann HE; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA USA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Kadota JL; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA., Namale C; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda., Kakeeto J; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda., Nakimuli J; Infectious Diseases Research Collaboration, Kampala, Uganda., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda., Berger C; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA., Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA., Cattamanchi A; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, CA USA., Semitala FC; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda., Kerkhoff AD; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA.; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
المصدر: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Sep 14. Date of Electronic Publication: 2023 Sep 14.
نوع المنشور: Preprint
بيانات الدورية: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
-
6دورية أكاديمية
المؤلفون: Semitala FC; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda., Kadota JL; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Nabunje J; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Bishop O; Infectious Diseases Research Collaboration, Kampala, Uganda., Patel D; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America., Sammann A; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America., Nahid P; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Belknap R; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America., Kamya MR; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda., Handley MA; Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America., Phillips PPJ; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Katahoire A; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Berger CA; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Kiwanuka N; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Katamba A; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda., Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Cattamanchi A; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
المصدر: PLoS medicine [PLoS Med] 2021 Dec 16; Vol. 18 (12), pp. e1003875. Date of Electronic Publication: 2021 Dec 16 (Print Publication: 2021).
نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
مواضيع طبية MeSH: Directly Observed Therapy*/classification, Antitubercular Agents/*therapeutic use , Isoniazid/*therapeutic use , Rifampin/*analogs & derivatives , Tuberculosis/*prevention & control, Adult ; Drug Therapy, Combination ; Female ; HIV Infections/etiology ; Humans ; Male ; Middle Aged ; Rifampin/therapeutic use ; Uganda
-
7دورية أكاديمية
المؤلفون: Semitala FC; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. semitala@gmail.com.; Makerere University Joint AIDS Program (MJAP), Kampala, Uganda. semitala@gmail.com.; Infectious Diseases Research Collaboration, Kampala, Uganda. semitala@gmail.com., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Ssemata J; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nabunje J; Infectious Diseases Research Collaboration, Kampala, Uganda., Kadota JL; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA., Berger CA; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA., Katamba A; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda., Kiwanuka N; School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda., Kamya MR; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda., Dowdy D; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Cattamanchi A; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.; Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, CA, USA., Katahoire AR; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Child Health and Development Centre, Makerere University College of Health Sciences, Kampala, Uganda.
المصدر: Implementation science communications [Implement Sci Commun] 2021 Jun 30; Vol. 2 (1), pp. 71. Date of Electronic Publication: 2021 Jun 30.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101764360 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-2211 (Electronic) Linking ISSN: 26622211 NLM ISO Abbreviation: Implement Sci Commun Subsets: PubMed not MEDLINE
-
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Kadota JL; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Nabunje J; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Ssemata JL; Infectious Diseases Research Collaboration, Kampala, Uganda., Bishop O; Makerere University Joint AIDS Program, Kampala, Uganda., Berger CA; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA., Patel D; Department of Surgery, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA., Sammann A; Department of Surgery, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA., Katahoire A; Child Health and Development Centre, Makerere University, Kampala, Uganda., Nahid P; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA., Belknap R; Denver Health and Hospital Authority, Denver, CO, USA.; Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, CO, USA., Phillips PPJ; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA., Namusobya J; University Research Company, Center for Human Services, Department of Defense HIV/AIDS Prevention Program (URC-DHAPP), Kampala, Uganda., Kamya M; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Handley MA; Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Kiwanuka N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala, Uganda., Katamba A; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda., Dowdy D; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Semitala FC; Infectious Diseases Research Collaboration, Kampala, Uganda. semitala@gmail.com.; Makerere University Joint AIDS Program, Kampala, Uganda. semitala@gmail.com.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. semitala@gmail.com.; Mulago- ISS Clinic, Old Mulago Hill Road, New Mulago Hospital Complex, P.O Box 7051, Kampala, Uganda. semitala@gmail.com., Cattamanchi A; Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, CA, USA.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
المصدر: Implementation science : IS [Implement Sci] 2020 Aug 12; Vol. 15 (1), pp. 65. Date of Electronic Publication: 2020 Aug 12.
نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101258411 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-5908 (Electronic) Linking ISSN: 17485908 NLM ISO Abbreviation: Implement Sci Subsets: MEDLINE
-
10دورية أكاديمية
المؤلفون: Gebreegziabher, Senedu Bekele, Ashuro, Akililu Alemu, Kumssa, Tsegaye Hailu, Teferi, Melese Yeshambaw, Alemayue, Endawoke Amsalu, Datiko, Daniel Gemechu, Yimer, Solomon Abebe, Shagre, Mulatu Biru
المصدر: BMC Infectious Diseases; 5/17/2024, Vol. 24 Issue 1, p1-11, 11p
مصطلحات موضوعية: COVID-19 pandemic, HIV-positive persons, IMMUNE reconstitution inflammatory syndrome, LATENT infection, HEALTH information systems, COVID-19
مصطلحات جغرافية: ADDIS Ababa (Ethiopia)